Overactive Bladder Syndrome. Overactive bladder
Conditions
Interventions
Intervention 1: Intervention group: Music therapy intervention is applied in 4 sessions of 60 minutes with a frequency of 1 time per week, as follows: 1) Presenting the collected pieces, including fun
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Age over 18 years Patients will be eligible if they document based on history several voiding or incontinence episodes/day associated with at least a moderate sensation of urgency in a voiding diary and agree to temporarily forgo other clinical OAB treatments Patients will be eligible if they are documented based on a history of nocturia Mean visual analog scale (VAS) score> 4 for at least 5 consecutive days Patients who will agree to participate in this trial and will provide written informed consent.
Exclusion criteria
Exclusion criteria: Patients reported a history of pelvic cancer or irradiation, prior bladder surgery, or other pelvic surgery in the past 3 months Patients reported a history of interstitial cystitis, bladder or rectal fistulas, congenital urinary tract defect, unilateral ureteral obstruction (UUO), symptomatic pelvic organ prolapse, benign prostatic hyperplasia (BPH), recurrent urinary tract infections (=3/year). Patients reported a history of diabetes mellitus, major neurologic conditions such as stroke or multiple sclerosis, and cardiovascular problems such as heart failure. Patients who experience side effects of anticholinergic drug Solifenacin such as angle-closure glaucoma will be immediately discontinued and excluded from the study. Pregnant patients or patients with pregnancy planning. Patients engaged in practitioner-administered behavioral relaxation therapies were excluded, participants were not precluded from using other informal self-administered relaxation practices. History of participating in another clinical trial within 2 months or planning to participate in another clinical trial. Not eligible to participate in this trial as a decision of the researchers
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Frequency of voiding. Timepoint: Before and after intervention. Method of measurement: International Consultation on Incontinence Modular Questionnaire on Lower Urinary Tract Symptoms (ICIQ-LUTS).;Nocturia. Timepoint: Before and after intervention. Method of measurement: International Consultation on Incontinence Modular Questionnaire on Lower Urinary Tract Symptoms (ICIQ-LUTS).;Urge urinary incontinence. Timepoint: Before and after intervention. Method of measurement: International Consultation on Incontinence Modular Questionnaire on Lower Urinary Tract Symptoms (ICIQ-LUTS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Bladder pain. Timepoint: Before and after intervention. Method of measurement: ICIQ-LUTS- quality of life (QOL) questionnaire.;Quality of life. Timepoint: Before and after intervention. Method of measurement: ICIQ-LUTS- quality of life (QOL) questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Masjedi
Shiraz University of Medical Sciences
Outcome results
None listed